| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 36.466 | 44.370 | 35.603 | 27.972 | 16.963 | 9.190 | 9.533 |
| Total Income - EUR | - | - | - | 36.492 | 44.370 | 34.614 | 27.972 | 16.963 | 9.190 | 9.533 |
| Total Expenses - EUR | - | - | - | 34.472 | 40.263 | 29.383 | 17.883 | 24.663 | 15.199 | 16.969 |
| Gross Profit/Loss - EUR | - | - | - | 2.020 | 4.107 | 5.231 | 10.089 | -7.700 | -6.009 | -7.436 |
| Net Profit/Loss - EUR | - | - | - | 1.469 | 3.664 | 4.885 | 9.524 | -7.870 | -6.101 | -7.532 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Tehno Andomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 7.016 | 6.678 | 2.349 | 11.881 | 5.438 | 4.565 | 2.521 |
| Inventories | - | - | - | 2.632 | 775 | 1.235 | 1.301 | 5.061 | 3.764 | 1.608 |
| Receivables | - | - | - | 3.266 | 5.608 | 1.040 | 9.854 | 209 | 156 | 632 |
| Cash | - | - | - | 1.118 | 295 | 74 | 725 | 168 | 645 | 281 |
| Shareholders Funds | - | - | - | -7.001 | -3.202 | 1.760 | 11.245 | 3.411 | -2.701 | -10.218 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 14.016 | 9.880 | 589 | 635 | 2.027 | 7.266 | 12.739 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Tehno Andomed S.r.l.